Unknown

Dataset Information

0

Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4.


ABSTRACT: Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), is a selective anticancer cytokine capable of exerting a targeted therapy approach. Disappointingly, recent research has highlighted the development of TRAIL resistance in cancer cells, thus minimising its usefulness in clinical settings. However, several recent studies have demonstrated that cancer cells can be sensitised to TRAIL through the employment of a combinatorial approach, utilizing TRAIL in conjunction with other natural or synthetic anticancer agents. In the present study, the chemo-sensitising effect of curcumin on TRAIL-induced apoptosis in renal carcinoma cells (RCC) was investigated. The results indicate that exposure of kidney cancer ACHN cells to curcumin sensitised the cells to TRAIL, with the combination treatment of TRAIL and curcumin synergistically targeting the cancer cells without affecting the normal renal proximal tubular epithelial cells (RPTEC/TERT1) cells. Furthermore, this combination treatment was shown to induce caspase-dependent apoptosis, inhibition of the proteasome, induction of ROS, upregulation of death receptor 4 (DR4), alterations in mitogen-activated protein kinase (MAPK) signalling and induction of endoplasmic reticulum stress. An in vivo zebrafish embryo study demonstrated the effectiveness of the combinatorial regime to inhibit tumour formation without affecting zebrafish embryo viability or development. Overall, the results arising from this study demonstrate that curcumin has the ability to sensitise TRAIL-resistant ACHN cells to TRAIL-induced apoptosis.

SUBMITTER: Obaidi I 

PROVIDER: S-EPMC7284747 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4.

Obaidi Ismael I   Cassidy Hilary H   Gaspar Verónica Ibáñez VI   McCaul Jasmin J   Higgins Michael M   Halász Melinda M   Reynolds Alison L AL   Kennedy Breandan N BN   McMorrow Tara T  

Biology 20200501 5


Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), is a selective anticancer cytokine capable of exerting a targeted therapy approach. Disappointingly, recent research has highlighted the development of TRAIL resistance in cancer cells, thus minimising its usefulness in clinical settings. However, several recent studies have demonstrated that cancer cells can be sensitised to TRAIL through the employment of a combinatorial approach, utilizing TRAIL in conjunction with other natura  ...[more]

Similar Datasets

| S-EPMC3731040 | biostudies-literature
| S-EPMC4237253 | biostudies-literature
| S-EPMC3064603 | biostudies-literature
| S-EPMC8241104 | biostudies-literature
| S-EPMC6310954 | biostudies-literature
| S-EPMC7551412 | biostudies-literature
| S-EPMC2928864 | biostudies-literature
| S-EPMC5908286 | biostudies-literature
| S-EPMC5108320 | biostudies-literature
| S-EPMC8026879 | biostudies-literature